Literature DB >> 15857843

Severe interstitial pneumonitis following rituximab and bleomycin-containing combination chemotherapy.

H Ghesquieres.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15857843     DOI: 10.1093/annonc/mdi232

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  4 in total

1.  Increased incidence of interstitial pneumonia by CHOP combined with rituximab.

Authors:  Daisuke Ennishi; Yasuhito Terui; Masahiro Yokoyama; Yuko Mishima; Shunji Takahashi; Kengo Takeuchi; Kazuma Ikeda; Mitsune Tanimoto; Kiyohiko Hatake
Journal:  Int J Hematol       Date:  2008-05       Impact factor: 2.490

2.  Rituximab-induced hypersensitivity pneumonitis.

Authors:  Adriano R Tonelli; Richard Lottenberg; Robert W Allan; P S Sriram
Journal:  Respiration       Date:  2008-10-09       Impact factor: 3.580

Review 3.  Infiltrative lung diseases: complications of novel antineoplastic agents in patients with hematological malignancies.

Authors:  Bobbak Vahid; Paul E Marik
Journal:  Can Respir J       Date:  2008 May-Jun       Impact factor: 2.409

4.  Rituximab-induced bronchiolitis obliterans organizing pneumonia.

Authors:  Ahmet B Ergin; Nancy Fong; Hamed A Daw
Journal:  Case Rep Med       Date:  2012-06-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.